Preclinical Evaluation of 64 Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging
Journal of Nuclear Medicine · 2026
DOI: 10.2967/jnumed.125.270555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Gyu Seong Heo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Washington University School of Medicine, St. Louis, Missouri; gheo@wustl.edu yongjianliu@wustl.edu. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Fibroblasts, Copper Radioisotopes, Serine Endopeptidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Fibroblast activation protein-expressing (FAP+) fibroblasts are central mediators of cardiac remodeling after injury or disease. The aim of this study was to evaluate a new PET tracer, 64Cu-LNTH-1363S, to detect FAP+ fibroblasts in myocardial infarction (MI) mouse models.
Methods
The permanent left anterior descending coronary artery ligation and the echocardiography-guided ischemia reperfusion models were used to assess the targeting efficiency of 64Cu-LNTH-1363S. Competitive receptor blocking and autoradiography studies were performed to confirm the in vivo targeting specificity.
Results
64Cu-LNTH-1363S demonstrated sensitive and specific detection of FAP+ cells in the 2 MI models. Kinetic modeling data showed that the distribution volume was higher in the infarct zone than in the remote myocardium.
Conclusion
This study establishes the feasibility of 64Cu-LNTH-1363S for noninvasive detection of FAP+ fibroblasts in MI mouse models and provides preclinical data to support further investigation of this process in humans after various forms of cardiac injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Washington University School of Medicine, St. Louis, Missouri; gheo@wustl.edu yongjianliu@wustl.edu.
- Department of Radiology, Washington University School of Medicine, St. Louis, Missouri.
- Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri; and.
- Lantheus, Billerica, Massachusetts.
Förderung
- NIH HHS
- NHLBI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Heo, G. S., Nai, Y. H., Otaegui, J. R., Yang, S., Luehmann, H. P., Yuan, G., Onthank, D., Ennis, M., Brown, J., Lavine, K. J., Gropler, R. J., & Liu, Y. (2026). Preclinical Evaluation of 64 Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270555
Vancouver
Heo GS, Nai YH, Otaegui JR, Yang S, Luehmann HP, Yuan G, et al. Preclinical Evaluation of 64 Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.125.270555
BibTeX
@article{Heo2026,
author = {Heo, Gyu Seong and Nai, Ying-Hwey and Otaegui, Jaume R and Yang, Steven and Luehmann, Hannah P and Yuan, Gengyang and Onthank, David and Ennis, Matt and Brown, Jeff and Lavine, Kory J and Gropler, Robert J and Liu, Yongjian},
title = {Preclinical Evaluation of 64 Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging},
journal = {Journal of Nuclear Medicine},
year = {2026},
doi = {10.2967/jnumed.125.270555}
}
EUVIMED